 VANCOUVER and HOUSTON, Dec. 15, 2020 PRNewswire - ESSA Pharma Inc. ESSA, or the Company NASDAQ: EPIX, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial... 